Impact of adding immunotherapy to chemotherapy for metastatic neuroendocrine bladder cancer in the National Cancer Database. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...
Development of an miRNA signature for individual prognostic assessment in seminoma patients. Test characteristics of ctDNA stratified by primary or post-chemotherapy RPLND.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback